Design Therapeutics, Inc.DSGNNASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank17
3Y CAGR-1.3%
5Y CAGR-5.7%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-1.3%/yr
Annual compound
5Y CAGR
-5.7%/yr
Recent acceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20250.78-10.4%
20240.87-0.8%
20230.88+8.0%
20220.81-2.0%
20210.83-21.0%
20201.05+1441.8%
20190.07-